PetMed Express Inc logo

PetMed Express Inc(PETS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.94
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for PETS

11/13/2026: PETS (1-star) is currently NOT-A-BUY. Pass it for now.

PetMed Express is a long-standing online retailer of pet medications and health products. The company currently faces a challenging competitive landscape against larger, omni-channel e-commerce retailers, which has pressured both its growth and margins. Its primary turnaround story involves pivoting toward higher-margin telehealth services and digital wellness tools to differentiate itself. Key risks include intense pricing pressure, high customer acquisition costs, and the ongoing execution risk associated with its business transformation. The stock may suit value-oriented investors who are closely monitoring the success of its new service-led initiatives, though it remains a higher-risk play in the crowded pet health sector.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe company is currently focused on stabilization and turnaround rather than aggressive top-line expansion.
Momentum investorWeak fitRecent price performance and market sentiment do not support a momentum-based thesis.
Value investorMixed fitValuation may appear attractive on a historical basis, but earnings stability remains a concern.
Dividend investorMixed fitWhile the dividend has been a feature, it is subject to the company's ability to maintain sufficient free cash flow.
Low-risk investorWeak fitThe volatility and competitive pressures in the pet retail space make this a higher-risk investment.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock is susceptible to sharp moves based on quarterly earnings results and retail competition reports.
Valuation riskMediumInvestors must weigh the potential for a turnaround against the risk of continued margin erosion.
Competition risk (E-commerce giants)HighAggressive pricing and fulfillment capabilities from larger retailers directly threaten PetMeds' core business.
Business qualityMediumThe company operates in a crowded space where brand loyalty is increasingly difficult to defend.
Dividend incomeMedium / highDividend sustainability is tied directly to the success of current turnaround initiatives.
Execution riskHighSuccess depends heavily on effectively executing a pivot toward pet health services.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 20.90M USD
Price to earnings Ratio -
1Y Target Price 1.4
Price to earnings Ratio -
1Y Target Price 1.4
Volume (30-day avg) 122.8K shares
Beta 0.83
52 Weeks Range 0.93 - 4.10
Updated Date 11/13/2026
52 Weeks Range 0.93 - 4.10
Updated Date 11/13/2026
Dividends yield (FY) -
Basic EPS (TTM) -1.23

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Industry classification is unavailable for this snapshot.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -12.42%
Avg. Invested days 39
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
PETS receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft company fundamentals, and soft analyst coverage.

Company Fundamentals

★★★★★
PETS has soft overall fundamentals (2 stars), with soft financial health, weak growth momentum, and solid ownership. In FY2026 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-667.5%), weak cash generation (FCF margin -18.4%), negative revenue growth (-34.7%).

Financial Health Rating

★★★★★
PETS's financial health is soft, with the relatively strongest area being moderate efficiency, including operating-expense and cost-of-revenue discipline (opex 40.4% of revenue). Profitability is soft (2 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
PETS's growth profile is soft, with the least-weak measure being revenue growth at -34.7% FY2026 versus FY2024. By comparison, while earnings growth (-667.5%, negative) and free-cash-flow growth (-16914.9%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 36.6% and approximately 62.7% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 17.31% supports management-shareholder alignment.

Top 5 Institutional Investors

Renaissance Technologies Corp 5.22%
Vanguard Capital Management, LLC 3.82%
BlackRock Inc 2.62%
Federated Hermes Inc 0.98%
Geode Capital Management, LLC 0.94%

Unit Economics (Per $1K Revenue)

★★★★★
PETS generates approximately $228 of gross profit, $-175 of operating income, and $-184 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.13%

Quantitative Style Profile

★★★★★
PETS has a liquid profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedSmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Pharmacy & RetailSale of prescription, non-prescription pet medications, and wellness products.The primary way the company generates revenue is by selling common pet health products online.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Valuation

Trailing PE -
Forward PE 16.69
Enterprise Value 10.87M
Price to Sales(TTM) 0.13
Enterprise Value 10.87M
Price to Sales(TTM) 0.13
Enterprise Value to Revenue 0.07
Enterprise Value to EBITDA 0.63
Shares Outstanding 22.23M
Shares Floating 13.94M
Shares Outstanding 22.23M
Shares Floating 13.94M
Percent Insiders 17.31
Percent Institutions 36.62

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.